201TL SPECT for evaluating head and neck cancer
- PMID: 8814712
- DOI: 10.1007/BF03165062
201TL SPECT for evaluating head and neck cancer
Abstract
Background: Thallium-201 (201Tl) has come to be widely used in diagnosis of several kinds of malignant tumor, but its usefulness in diagnosing head and neck cancer has not been established.
Purpose: This study investigated the usefulness of 201Tl SPECT imaging in patients with head and neck cancer histologically confirmed.
Methods: Eighteen patients with histologically proven head and neck cancer were studied. 201Tl SPECT images were obtained both 15 min and 4 hours after intravenous injection of 148 MBq of 201Tl-chloride. 201Tl-indices were calculated semiquantitatively to assess the tracer uptake in relation to tumor size and histological type.
Results: High 201Tl uptake was noted in all primary tumors and metastatic lymph nodes on the both early and delayed images, but 201Tl-indices did not show any correlation with tumor size or histological type.
Conclusion: Primary had and neck cancer and lymph node metastasis can be effectively visualized with 201Tl SPECT. It may provide information in addition to morphological changes and may be supplemental method to use in the evaluation of head and neck cancer.
Similar articles
-
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1689-700. doi: 10.1007/s00259-003-1345-4. Epub 2003 Oct 22. Eur J Nucl Med Mol Imaging. 2003. PMID: 14574516 Review.
-
Correlative 201Tl SPECT, MRI and ex vivo 201Tl uptake in detecting and characterizing cervical lymphadenopathy in head and neck squamous cell carcinoma.J Nucl Med. 1999 Sep;40(9):1414-9. J Nucl Med. 1999. PMID: 10492358
-
Thallium-201 SPECT in the diagnosis of head and neck cancer.J Nucl Med. 1997 Jun;38(6):873-9. J Nucl Med. 1997. PMID: 9189132
-
Comparison of thallium-201 and gallium-67 imaging in evaluation of head and neck tumors.J Comput Assist Tomogr. 2000 May-Jun;24(3):454-60. doi: 10.1097/00004728-200005000-00019. J Comput Assist Tomogr. 2000. PMID: 10864086
-
Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.Arch Otolaryngol Head Neck Surg. 1996 May;122(5):509-14. doi: 10.1001/archotol.1996.01890170043009. Arch Otolaryngol Head Neck Surg. 1996. PMID: 8615968 Review.
Cited by
-
Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.Ann Nucl Med. 2013 Feb;27(2):163-9. doi: 10.1007/s12149-012-0669-1. Epub 2012 Nov 28. Ann Nucl Med. 2013. PMID: 23188388 Free PMC article.
-
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1689-700. doi: 10.1007/s00259-003-1345-4. Epub 2003 Oct 22. Eur J Nucl Med Mol Imaging. 2003. PMID: 14574516 Review.
-
Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):528-31. doi: 10.1007/s00259-003-1428-2. Epub 2004 Jan 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14722682 Clinical Trial.
-
Thallium-201 single-photon emission CT in recurrent squamous cell carcinoma of the head and neck.AJNR Am J Neuroradiol. 2002 Jan;23(1):174-5. AJNR Am J Neuroradiol. 2002. PMID: 11827893 Free PMC article. No abstract available.
-
Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.AJNR Am J Neuroradiol. 1999 Aug;20(7):1215-20. AJNR Am J Neuroradiol. 1999. PMID: 10472974 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical